Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENTASA Enema in Chinese Patients with Left-sided Active Ulcerative Colitis
NCT02368717Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Mar 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ulcerative colitis (UC) comparing Mesalazine with Placebo (2 arms). Primary endpoint: Clinical remission after 4 weeks treatment. Started Mar 2015; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02368717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368717.